A novel cell-free therapy using exosomes in the inner ear regeneration

Tissue Cell. 2024 Apr 9;88:102373. doi: 10.1016/j.tice.2024.102373. Online ahead of print.ABSTRACTCellular and molecular alterations associated with hearing loss are now better understood with advances in molecular biology. These changes indicate the participation of distinct damage and stress pathways that are unlikely to be fully addressed by conventional pharmaceutical treatment. Sensorineural hearing loss is a common and debilitating condition for which comprehensive pharmacologic intervention is not available. The complex and diverse molecular pathology that underlies hearing loss currently limits our ability to intervene with small molecules. The present review focuses on the potential for the use of extracellular vesicles in otology. It examines a variety of inner ear diseases and hearing loss that may be treatable using exosomes (EXOs). The role of EXOs as carriers for the treatment of diseases related to the inner ear as well as EXOs as biomarkers for the recognition of diseases related to the ear is discussed.PMID:38640600 | DOI:10.1016/j.tice.2024.102373
Source: Tissue and Cell - Category: Cytology Authors: Source Type: research